Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.

K Wynne, AJ Park, CJ Small, M Patterson, SM Ellis, KG Murphy, AM Wren, GS Frost, K Meeran, MA Ghatei, SR Bloom

Research output: Contribution to journalArticlepeer-review

Original languageUndefined
JournalDIABETES
DOIs
Publication statusPublished - Aug 2005

Cite this